AC
Acro Biomedical Co., Ltd.
ACBM · OTC
$0.03 +0.00% (+$0.00)
Market Cap $1.56M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.03
15.4% upside
Current Price
$0.026
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACBM is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 352.35%
Asset turnover 0.00x
ROA 3,849.04%
Debt
0 /100
High Current ratio 0.01x
Int. coverage -15.92x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -2.38x
Profitable years 0
EPS volatility 126.70%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACBM
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jing Zhou Chen
Employees
1
Headquarters
Fishers